EP1325120A4 - Acides nucleiques et polypeptides - Google Patents

Acides nucleiques et polypeptides

Info

Publication number
EP1325120A4
EP1325120A4 EP01977088A EP01977088A EP1325120A4 EP 1325120 A4 EP1325120 A4 EP 1325120A4 EP 01977088 A EP01977088 A EP 01977088A EP 01977088 A EP01977088 A EP 01977088A EP 1325120 A4 EP1325120 A4 EP 1325120A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01977088A
Other languages
German (de)
English (en)
Other versions
EP1325120A2 (fr
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1325120A2 publication Critical patent/EP1325120A2/fr
Publication of EP1325120A4 publication Critical patent/EP1325120A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01977088A 2000-10-12 2001-10-11 Acides nucleiques et polypeptides Withdrawn EP1325120A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68752700A 2000-10-12 2000-10-12
US687527 2000-10-12
PCT/US2001/027760 WO2002031111A2 (fr) 2000-10-12 2001-10-11 Acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1325120A2 EP1325120A2 (fr) 2003-07-09
EP1325120A4 true EP1325120A4 (fr) 2005-05-25

Family

ID=24760764

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01977088A Withdrawn EP1325120A4 (fr) 2000-10-12 2001-10-11 Acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1325120A4 (fr)
AU (1) AU2001296235A1 (fr)
CA (1) CA2425827A1 (fr)
WO (1) WO2002031111A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (fr) * 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001034636A1 (fr) * 1999-11-05 2001-05-17 The General Hospital Corporation Molecules d'acides nucleiques et polypeptides grl (gridlock), et methodes diagnostiques et therapeutiques associees
US8642284B1 (en) 1999-12-15 2014-02-04 Massachusetts Institute Of Technology Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
US7452664B2 (en) 1999-12-15 2008-11-18 Massachusetts Institute Of Technology Methods for identifying agents which alter histone protein acetylation
US7510855B2 (en) 2000-01-26 2009-03-31 Agensys, Inc. 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer
WO2002000939A2 (fr) 2000-06-28 2002-01-03 Diadexus, Inc. Procede de diagnostic, de surveillance, de determination du stade, d'imagerie et de traitement du cancer du colon
JP2002034565A (ja) * 2000-07-19 2002-02-05 Japan Science & Technology Corp 細菌ｄｎａを特異的に認識する受容体タンパク質
WO2002030963A1 (fr) * 2000-10-12 2002-04-18 Exelixis, Inc. Ect2 humain et procedes d'utilisation
US20060127890A1 (en) * 2000-10-30 2006-06-15 Nobuyuki Koyama Novel gene overexpressed in heart and skeletal muscle and use thereof
US7572575B2 (en) 2000-12-13 2009-08-11 Massachusetts Institute Of Technology SIR2 activity
MXPA03005436A (es) 2000-12-20 2004-05-05 Bristol Myers Squibb Co Polinucleotidos novedosos que codifican fosfastasas humanas.
EP1383797A2 (fr) * 2001-02-07 2004-01-28 Universiteit Maastricht Marqueurs de plaques d'atherosclerose instables
DE60230051D1 (de) * 2001-04-10 2009-01-08 Agensys Inc Nukleinsäure und entsprechendes protein mit der bezeichnung 121p2a3 zur behandlung und zum nachweis von krebs
WO2002098356A2 (fr) * 2001-06-05 2002-12-12 Exelixis Inc. Genes de ppp2c en tant que modificateurs de la voie p53 et methodes d'utilisation
WO2003004989A2 (fr) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, trousses, et procedes d'identification, d'evaluation, de prevention, et de therapie pour le cancer du sein
JP2003024080A (ja) * 2001-07-19 2003-01-28 Univ Tokyo ｐ５３依存性アポトーシス誘導タンパク質、およびアポトーシス調節剤のスクリーニング方法
WO2004005512A1 (fr) * 2002-07-09 2004-01-15 Takeda Pharmaceutical Company Limited Proteine et utilisation
JP4301541B2 (ja) * 2002-09-05 2009-07-22 独立行政法人科学技術振興機構 Ｓｍｇ−１結合タンパク質及びその活性を制御する物質のスクリーニング方法
US20060199181A1 (en) * 2002-09-11 2006-09-07 Genentch, Inc. Compositions and methods for the treatment of immune related diseases
AU2003279322A1 (en) * 2002-11-08 2004-06-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3)
AU2003901055A0 (en) * 2003-02-17 2003-03-20 Nathan E Hall Methods for inhibiting signal transduction
JP2006525031A (ja) * 2003-05-07 2006-11-09 ユニバーシティー オブ マサチューセッツ Ａｃｈｅｒｏｎ発現の制御方法
WO2004112575A2 (fr) * 2003-06-20 2004-12-29 Amgen Inc. Amplification et surexpression geniques dans le cancer
WO2005014817A2 (fr) * 2003-08-07 2005-02-17 Compugen Ltd. Homologues de type chordine
JP2008502307A (ja) * 2003-10-28 2008-01-31 プロテミックス ディスカバリー リミティド 抗肥満活性及び他の関連用途を有するペプチド
KR100878959B1 (ko) 2004-02-09 2009-01-19 에자이 알앤드디 매니지먼트 가부시키가이샤 스크리닝 방법
US20080199468A1 (en) * 2004-02-24 2008-08-21 Oncotherapy Science, Inc. Method For Diagnosing Colorectal Cancers
EP2169060B1 (fr) * 2004-06-02 2011-12-07 TSS Biotech Inc. Nouveau polypeptide utile pour diagnostiquer et pour traiter le cancer
AU2005277508B2 (en) 2004-08-16 2011-04-14 Quark Pharmaceuticals, Inc Therapeutic uses of inhibitors of RTP801
US7531634B2 (en) * 2004-12-03 2009-05-12 University Of Pittsburgh Bladder matrix protein peptides and methods of detection of bladder cancer
EP1856278A2 (fr) * 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Methode de diagnostic du cancer de la vessie
US20070099830A1 (en) 2005-04-21 2007-05-03 Massachusetts Institute Of Technology Sirt4 activities
WO2006115295A1 (fr) * 2005-04-25 2006-11-02 University Of Yamanashi Compositions et methodes de traitement de troubles hemostatiques associes a la transduction du signal du clec-2
NL2000439C2 (nl) 2006-01-20 2009-03-16 Quark Biotech Therapeutische toepassingen van inhibitoren van RTP801.
US7723052B2 (en) 2006-05-11 2010-05-25 Quark Pharmaceuticals, Inc. Screening systems utilizing RTP801
EP2026843A4 (fr) 2006-06-09 2011-06-22 Quark Pharmaceuticals Inc Utilisations thérapeutiques d'inhibiteurs de rtp801l
KR101454287B1 (ko) 2006-10-17 2014-11-04 온코세라피 사이언스 가부시키가이샤 Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
WO2008106102A2 (fr) 2007-02-26 2008-09-04 Quark Pharmaceuticals, Inc. Inhibiteurs de rtp801 et leur utilisation dans le traitement de diverses maladies
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JP2011529501A (ja) * 2008-07-28 2011-12-08 イデラ ファーマシューティカルズ インコーポレイテッド アンチセンスオリゴヌクレオチドによるＴｏｌｌ様受容体９発現の調節
US8975086B2 (en) 2008-08-28 2015-03-10 Oncotherapy Science, Inc. Method for treating or preventing bladder cancer using the DEPDC1 polypeptide
CN102356155B (zh) 2009-03-18 2016-02-24 肿瘤疗法科学股份有限公司 Neil3肽及包含它的疫苗
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
GB201009654D0 (en) * 2010-06-09 2010-07-21 Cancer Res Technology Nucleic acid methyltransferase
TWI467016B (zh) * 2011-08-31 2015-01-01 Taipei Veteran General Hospital Ｏｃｔ４及ＳｉｒＴ１之基因傳遞及其醫藥組合物
US10653782B2 (en) * 2014-11-25 2020-05-19 Nortwestern University Retroviral particles expressing Sirt1 embedded within PPCN
JP6934250B2 (ja) 2015-08-12 2021-09-15 オンコセラピー・サイエンス株式会社 Ｄｅｐｄｃ１由来ペプチドおよびそれを含むワクチン

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (fr) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 proteines humaines secretees
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (fr) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 proteines humaines secretees
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 October 1998 (1998-10-01), XP002307625, retrieved from EBI Database accession no. AI148629 *
DATABASE EMBL [online] 22 May 2001 (2001-05-22), NI ET AL., XP002307627, retrieved from EBI Database accession no. AAF91870 *
DATABASE EMBL [online] 3 March 2000 (2000-03-03), ZHANG ET AL., XP002307624, retrieved from EBI Database accession no. AF151068 *
DATABASE GENSEQ [online] 27 August 2002 (2002-08-27), ROSEN ET AL., XP002307628, retrieved from EBI Database accession no. ABG65339 *
DATABASE GENSEQ 22 May 2001 (2001-05-22), NI ET AL., XP002307626, retrieved from EBI Database accession no. AAB87354 *
See also references of WO0231111A3 *
ZHANG ET AL: "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoetic stem/progenitor cells", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 10, no. 10, October 2000 (2000-10-01), pages 1546 - 1560, XP002215896, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
AU2001296235A1 (en) 2002-04-22
WO2002031111A3 (fr) 2002-10-17
WO2002031111A2 (fr) 2002-04-18
EP1325120A2 (fr) 2003-07-09
CA2425827A1 (fr) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1242443A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001277840A1 (en) Novel nucleic acids and polypeptides
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001263005A8 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030415

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7C 12N 15/12 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050406

17Q First examination report despatched

Effective date: 20050524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050928